Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Annals of Clinical and Translational Neurology|February 28, 2023
Corneal nerve loss predicts dementia in patients with mild cognitive impairmentGeorgios Ponirakis, Hanadi Al Hamad, Dunya A M Omar, et al.Annals of Clinical and Translational Neurology|April 26, 2019
Association of corneal nerve fiber measures with cognitive function in dementiaGeorgios Ponirakis, Hanadi Al Hamad, Anoop Sankaranarayanan, et al.Therapeutic Advances in Neurological Disorders|February 13, 2023
Corneal axonal loss as an imaging biomarker of neurodegeneration in multiple sclerosis: a longitudinal studyIoannis N Petropoulos, Fatima Al-Shibani, Gulfidan Bitirgen, et al.Alzheimer'S & Dementia (New York, N. Y.)|April 13, 2022
Loss of corneal nerves and brain volume in mild cognitive impairment and dementiaGeorgios Ponirakis, Hanadi Al Hamad, Adnan Khan, et al.Journal of Diabetes Investigation|April 21, 2022
Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf regionGeorgios Ponirakis, Tarik Elhadd, Ebaa Al Ozairi, et al.Frontiers in Neuroscience|July 8, 2021
Association of Cerebral Ischemia With Corneal Nerve Loss and Brain Atrophy in MCI and DementiaGeorgios Ponirakis, Ahmed Elsotouhy, Hanadi Al Hamad, et al.Journal of Alzheimer'S Disease : JAD|September 14, 2020
Corneal Nerve and Brain Imaging in Mild Cognitive Impairment and DementiaEiman Al-Janahi, Georgios Ponirakis, Hanadi Al Hamad, et al.Journal of Diabetes Investigation|June 2, 2022
Progressive loss of corneal nerve fibers is associated with physical inactivity and glucose lowering medication associated with weight gain in type 2 diabetesGeorgios Ponirakis, Ibrahim Al-Janahi, Einas Elgassim, et al.Frontiers in Neuroscience|July 17, 2024
Sustained corneal nerve loss predicts the development of diabetic neuropathy in type 2 diabetesGeorgios Ponirakis, Ibrahim Al-Janahi, Einas Elgassim, et al.Journal of the Peripheral Nervous System : JPNS|October 23, 2024
Glucose-lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetesGeorgios Ponirakis, Ibrahim Al-Janahi, Einas Elgassim, et al.Pageof 7